Auditory function after continuous infusion of gentamicin to high-risk newborns.
Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.
Colding
H
H
Institute of Medical Microbiology, University of Copenhagen, Denmark.
Andersen
E A
EA
Prytz
S
S
Wulffsberg
H
H
Andersen
G E
GE
D001299:Audiometry; D001309:Auditory Threshold / Q000187:drug effects*; D005500:Follow-Up Studies; D005839:Gentamicins / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007363:Intensive Care Units, Neonatal
D005839:Gentamicins